BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Treatment
46 results:

  • 1. Evolutionary trajectories of small cell lung cancer under therapy.
    George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
    Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
    Kobayashi K; Saito Y; Kage H; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
    Jpn J Clin Oncol; 2023 Aug; 53(9):798-807. PubMed ID: 37357968
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Knockdown of ACC1 promotes migration of esophageal cancer cell].
    Qian H; Gu CW; Liu YZ; Zhao BS
    Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):482-489. PubMed ID: 37355466
    [No Abstract]    [Full Text] [Related]  

  • 4. An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas.
    Gupta AK; Kumar M
    Cancer Biomark; 2023; 36(1):31-52. PubMed ID: 36245368
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Various clinical scenarios of primary melanoma of the esophagus: A retrospective 20-year analysis from two university thoracic surgery centers.
    Stępień K; Skorek P; Włodarczyk J; Wójcik J; Smęder T; Trybalski Ł; Rudnicka-Sosin L; Kużdżał J; Kocoń P
    Adv Clin Exp Med; 2022 Mar; 31(3):337-344. PubMed ID: 35349229
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular mechanisms associated with chemoresistance in esophageal cancer.
    Lohan-Codeço M; Barambo-Wagner ML; Nasciutti LE; Ribeiro Pinto LF; Meireles Da Costa N; Palumbo A
    Cell Mol Life Sci; 2022 Feb; 79(2):116. PubMed ID: 35113247
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inhibition of histone acetyltransferase function radiosensitizes crebbp/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.
    Kumar M; Molkentine D; Molkentine J; Bridges K; Xie T; Yang L; Hefner A; Gao M; Bahri R; Dhawan A; Frederick MJ; Seth S; Abdelhakiem M; Beadle BM; Johnson F; Wang J; Shen L; Heffernan T; Sheth A; Ferris RL; Myers JN; Pickering CR; Skinner HD
    Nat Commun; 2021 Nov; 12(1):6340. PubMed ID: 34732714
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of a deformable image registration quality assurance tool for head and neck cancer patients.
    Mee M; Stewart K; Lathouras M; Truong H; Hargrave C
    J Med Radiat Sci; 2020 Dec; 67(4):284-293. PubMed ID: 33615738
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Distinguishing Patients With Distant Metastatic Differentiated Thyroid cancer Who Biochemically Benefit From Next Radioiodine treatment.
    Sa R; Cheng L; Jin Y; Fu H; Shen Y; Chen L
    Front Endocrinol (Lausanne); 2020; 11():587315. PubMed ID: 33304320
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of surgical resection margins less than 5 mm in oral cavity squamous cell carcinoma: a systematic review.
    Bungum A; Jensen JS; Jakobsen KK; Christensen A; Grønhøj C; von Buchwald C
    Acta Otolaryngol; 2020 Oct; 140(10):869-875. PubMed ID: 32564643
    [No Abstract]    [Full Text] [Related]  

  • 11. β-Catenin/cbp inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
    Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
    Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer.
    Zenga J; Divi V; Stadler M; Massey B; Campbell B; Shukla M; Awan M; Schultz CJ; Shreenivas A; Wong S; Jackson RS; Pipkorn P
    Oral Oncol; 2019 Nov; 98():125-131. PubMed ID: 31586894
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways.
    Wang J; Wu M; Zheng D; Zhang H; Lv Y; Zhang L; Tan HS; Zhou H; Lao YZ; Xu HX
    Acta Pharmacol Sin; 2020 Jan; 41(1):82-92. PubMed ID: 31371781
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Inhibition of cbp/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.
    Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J
    Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells.
    Tsai CN; Tsai CL; Yi JS; Kao HK; Huang Y; Wang CI; Lee YS; Chang KP
    Sci Rep; 2019 Mar; 9(1):5197. PubMed ID: 30914776
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Patterns of Practice in Canadian Radiation treatment Centres: Results of a National Survey.
    Giddings A; Nica L; French J; Davis CA; Smoke M; Bolderston A
    J Med Imaging Radiat Sci; 2018 Mar; 49(1):23-30. PubMed ID: 30479283
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck.
    Weiss J; Gilbert J; Deal AM; Weissler M; Hilliard C; Chera B; Murphy B; Hackman T; Liao JJ; Grilley Olson J; Hayes DN
    Oral Oncol; 2018 Sep; 84():46-51. PubMed ID: 30115475
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
    Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
    J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/cbp activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Apigenin inhibits C5a-induced proliferation of human nasopharyngeal carcinoma cells through down-regulation of C5aR.
    Zhang Y; Cao Y; Zhang L; Feng C; Zhou G; Wen G
    Biosci Rep; 2018 May; 38(3):. PubMed ID: 29685955
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.